
The Melanoma Institute (MIA) is an independent, non - profit organisation located in North Sydney. MIA is formally affiliated with the University of Sydney and collaborates with individuals at St Vincent's and Mater Health, Royal Prince Alfred Hospital and at the University of Sydney to improve the outcome of patients with melanoma. Each year around 1,200 new melanoma patients are referred to the Institute and approximately 12,000 follow-ups occur. MIA has become a major referral centre for melanoma patients in NSW and overseas.
Melanoma Institute Australia (MIA) is seeking an experienced Clinical Trials Clinical Leader to provide clinical, operational and professional leadership across our Clinical Trials Unit.
This is a 12-month fixed-term maternity leave cover position, providing an opportunity to take on a senior leadership role within our Clinical Trials Unit.
Our Clinical Trials Team coordinates around 40 clinical trials at any one time, providing patients with access to new and investigative treatments while contributing to important melanoma research. The Clinical Trials Clinical Leader works closely with the Clinical Trials Management Team and Team Leaders to support the safe, compliant and efficient delivery of clinical trials. The role provides leadership across clinical operations, staff development, workforce planning and quality improvement.
Key Responsibilities
About You
To be successful in this role, you will have:
This is an outstanding opportunity to advance your career at a globally recognised institution. You'll play a vital role in supporting melanoma patients while contributing to groundbreaking cancer research.
Only applicants with full working rights within Australia should apply. Student visa holders are not eligible for this role.Only successful applicants will be contacted. Please no recruitment agencies.
Application will close on 14 September 2026 Due to the overwhelming response, we will only be contacting candidates we wish to interview.
We pay our respects to the Traditional Custodians of the lands on which Melanoma Institute Australia works, and their Elders both past and present, and acknowledge the deep, continuing connection of Aboriginal and Torres Strait Islander peoples to the land, waters, and sky.

The Royal Children's Hospital (RCH) has been providing outstanding care for Victoria's children and their families for over 147 years.
We are the major specialist paediatric hospital in Victoria and our care extends to children from Tasmania, southern New South Wales and other states around Australia and overseas.
With a passionate, highly skilled and committed staff campus wide of over 5,000, we provide a full range of clinical services, tertiary care and health promotion and prevention programs for children and young people.
We are the designated state-wide major trauma centre for paediatrics in Victoria and a Nationally Funded Centre for cardiac and liver transplantation.
When it comes to training and research we partner with the very best. Our campus partners, the Murdoch Childrens Research Institute (MCRI) and The University of Melbourne Department of Paediatrics, along with the RCH Foundation, are on site with the hospital in Parkville. Together, we are committed to improving the health outcomes for children today and in the future.
In 2016–17, more than 85,654 children attended our Emergency Department, 322,291 specialist clinic appointments were held which was almost 70,000 more than the previous year, more than 17,000 surgeries were performed and more than 48,552 children were admitted to our wards.